HomeCompareGLGDF vs ABBV

GLGDF vs ABBV: Dividend Comparison 2026

GLGDF yields 100.50% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLGDF wins by $3.87M in total portfolio value
10 years
GLGDF
GLGDF
● Live price
100.50%
Share price
$1.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.98M
Annual income
$1,344,629.06
Full GLGDF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — GLGDF vs ABBV

📍 GLGDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLGDFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLGDF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLGDF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLGDF
Annual income on $10K today (after 15% tax)
$8,542.71/yr
After 10yr DRIP, annual income (after tax)
$1,142,934.70/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, GLGDF beats the other by $1,121,878.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLGDF + ABBV for your $10,000?

GLGDF: 50%ABBV: 50%
100% ABBV50/50100% GLGDF
Portfolio after 10yr
$2.04M
Annual income
$684,700.41/yr
Blended yield
33.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

GLGDF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
10.8
Piotroski
6/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLGDF buys
0
ABBV buys
0
No recent congressional trades found for GLGDF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLGDFABBV
Forward yield100.50%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$3.98M$102.3K
Annual income after 10y$1,344,629.06$24,771.77
Total dividends collected$3.55M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: GLGDF vs ABBV ($10,000, DRIP)

YearGLGDF PortfolioGLGDF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$20,750$10,050.25$11,550$430.00+$9.2KGLGDF
2$41,693$19,490.21$13,472$627.96+$28.2KGLGDF
3$81,211$36,599.26$15,906$926.08+$65.3KGLGDF
4$153,521$66,625.28$19,071$1,382.55+$134.4KGLGDF
5$281,976$117,708.81$23,302$2,095.81+$258.7KGLGDF
6$503,770$202,055.30$29,150$3,237.93+$474.6KGLGDF
7$876,403$337,369.86$37,536$5,121.41+$838.9KGLGDF
8$1,486,274$548,522.61$50,079$8,338.38+$1.44MGLGDF
9$2,459,685$869,372.01$69,753$14,065.80+$2.39MGLGDF
10$3,976,493$1,344,629.06$102,337$24,771.77+$3.87MGLGDF

GLGDF vs ABBV: Complete Analysis 2026

GLGDFStock

GoGold Resources Inc. engages in the exploration, development, and production of gold and silver primarily in Mexico. The company holds an interest in the Parral Tailings project, which covers an area of 141 hectares located in the state of Chihuahua, Mexico. It also holds an option to acquire 100% concessions of the Los Ricos project, which covers 42 concessions with an area of approximately 22,000 hectares situated in the Jalisco State, Mexico. The company is headquartered in Halifax, Canada.

Full GLGDF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this GLGDF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLGDF vs SCHDGLGDF vs JEPIGLGDF vs OGLGDF vs KOGLGDF vs MAINGLGDF vs JNJGLGDF vs MRKGLGDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.